The Orally Administered Selective TRPV1 Antagonist, JTS-653, Attenuates Chronic Pain Refractory to Non-steroidal Anti-inflammatory Drugs in Rats and Mice Including Post-herpetic Pain
スポンサーリンク
概要
- 論文の詳細を見る
- 2013-06-20
著者
-
Matsushita Mutsuyoshi
Central Pharmaceutical Research Institute Japan Tobacco Inc.
-
Sakata Masahiro
Central Pharmaceutical Research Institute, Japan Tobacco Inc., Japan
-
Hamada Yuji
Central Pharmaceutical Research Institute, Japan Tobacco Inc., Japan
-
Usui Kenji
Central Pharmaceutical Research Institute, Japan Tobacco Inc., Japan
-
Wada Masashi
Central Pharmaceutical Research Institute, Japan Tobacco Inc., Japan
-
TAMAI Isao
Central Pharmaceutical Research Institute, Japan Tobacco Inc.
-
KITAGAWA Yoshihiro
Central Pharmaceutical Research Institute, Japan Tobacco Inc.
-
USUI Kenji
Central Pharmaceutical Research Institute, Japan Tobacco Inc.
-
WADA Masashi
Central Pharmaceutical Research Institute, Japan Tobacco Inc.
関連論文
- Effects of preventing hyperphagia on glycolipid metabolic abnormalities in Spontaneously Diabetic Torii fatty rats
- 雌性SDT(Spontaneously Diabetic Torii)fattyラットの病態解析
- The Orally Administered Selective TRPV1 Antagonist, JTS653, Attenuates Chronic Pain Refractory to Non-steroidal Anti-inflammatory Drugs in Rats and Mice Including Post-herpetic Pain
- The Orally Administered Selective TRPV1 Antagonist, JTS-653, Attenuates Chronic Pain Refractory to Non-steroidal Anti-inflammatory Drugs in Rats and Mice Including Post-herpetic Pain